05/19/2025
6:18 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
3:26 PM | Ionis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2025
3:27 PM | Ionis Pharmaceuticals (Filer)
| Form ARS | |
04/17/2025
3:53 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
3:53 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
3:53 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
8:35 AM | BlackRock, Inc. (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/16/2025
4:38 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2025
4:40 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2025
4:41 PM | Ionis Pharmaceuticals (Subject)
Jenne Kyle (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for IONS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ionis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/13/2025
3:45 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:17 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:06 PM | Ionis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
3:53 PM | Capital World Investors (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/07/2025
10:55 AM | Ionis Pharmaceuticals (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/06/2025
5:26 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
5:27 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:56 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
6:26 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:26 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:26 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:26 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:27 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:27 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:27 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:43 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
4:41 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
4:01 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
4:02 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
4:03 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:58 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
3:59 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
6:40 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
01/17/2025
6:40 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:40 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:41 PM | Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
6:31 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:18 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:19 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:21 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:22 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:23 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:25 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:28 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:29 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
6:30 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
10:29 AM | Ionis Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/06/2025
3:52 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:52 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:52 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:52 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:57 PM | Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
1:28 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:34 PM | BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
7:55 AM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
11/08/2024
9:52 AM | Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/06/2024
3:06 PM | Ionis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
5:39 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
5:42 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
5:01 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
5:01 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:19 PM | Ionis Pharmaceuticals (Filer)
| Form 424B5 | |
09/09/2024
3:33 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
3:23 PM | Ionis Pharmaceuticals (Filer)
| Form 424B5 | |
09/04/2024
8:43 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:43 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:51 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:23 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
09/04/2024
8:24 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144/A | |
09/04/2024
8:25 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:27 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:29 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:33 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
09/04/2024
8:33 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
09/04/2024
8:40 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Is The Moment You Betray Trump (Or Prove Them Wrong) (Ad) They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down.
This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings. Protect your savings without betraying Trump |
09/04/2024
8:40 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:41 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:19 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144/A | |
09/04/2024
8:20 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144/A | |
09/04/2024
8:21 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:02 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4/A | |
09/04/2024
8:06 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4/A | |
09/04/2024
8:11 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4/A | |
09/04/2024
8:13 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
Buy IONS Stock Free IONS Stock Alerts